Journal
MOLECULAR BRAIN
Volume 7, Issue -, Pages -Publisher
BMC
DOI: 10.1186/1756-6606-7-22
Keywords
Induced pluripotent stem cell; Cell transplantation; Spinal cord injury; Modeling human diseases; Parkinson's disease; Alzheimer's disease
Categories
Funding
- Program for Intractable Disease Research Utilizing Disease-specific iPS Cells - Japan Science and Technology Agency (JST)
Ask authors/readers for more resources
In 2006, we demonstrated that mature somatic cells can be reprogrammed to a pluripotent state by gene transfer, generating induced pluripotent stem (iPS) cells. Since that time, there has been an enormous increase in interest regarding the application of iPS cell technologies to medical science, in particular for regenerative medicine and human disease modeling. In this review article, we outline the current status of applications of iPS technology to cell therapies (particularly for spinal cord injury), as well as neurological disease-specific iPS cell research (particularly for Parkinson's disease and Alzheimer's disease). Finally, future directions of iPS cell research are discussed including a) development of an accurate assay system for disease-associated phenotypes, b) demonstration of causative relationships between genotypes and phenotypes by genome editing, c) application to sporadic and common diseases, and d) application to preemptive medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available